JAHA:研究中所用测压方法对临床结局的影响!

2017-02-14 xing.T MedSci原创

这些结果表明,将SPRINT研究的结果用于临床需要按照研究中的血压测量方法进行血压测量,而不是用常规临床测量方法进行代替。然而,即使将SPRINT研究的结果用于大型人群中,SPRINT的BP测量方法仍是较少被使用。

收缩压干预试验(SPRINT研究)已经发现当血压达到目标值收缩压120mmHg时,相比于收缩压达到140mmHg的目标值,高血压患者心血管疾病的发病率和死亡率下降了25%;然而,血压的测量是采用该研究的测压技术。SPRINT研究中血压测量方法如下:在一个安静的房间里坐下休息5分钟随后在房间里没有观察者的情况下进行3示波法测压。然而这种研究中所用的测压方法与常规血压测量方法之间有何联系尚未有研究报道,近日,心血管疾病领域权威杂志JAHA上针对这一问题发表了一篇研究文章。

在275例来诊室就诊的血压值低于140/90mmHg的慢性肾脏病患者中,研究人员对这些参与者采用SPRINT研究中所用的血压测量方法测量其血压,并且在同一天通过没有规范的坐下休息后测量并记录参与者的血压。

与常规测压方法相比,研究所用方法测得的收缩压要低12.7 mm Hg,并且有较广的允许范围(−46.1至20.7mmHg)。研究所用方法测得的收缩压比白天动态收缩压要低7.9mmHg,并且有广泛的允许范围(−33.2至17.4mmHg)。而常规方法所得收缩压、研究方法所得收缩压和白天动态收缩压都与左室肥厚的超声指标相关,研究方法所得收缩压和白天动态收缩压与左心室肥厚之间的相关性强度相似,但是比常规方法所得的收缩压与左心室肥厚之间的相关性要更强。

总之,这些结果表明,将SPRINT研究的结果用于临床需要按照研究中的血压测量方法进行血压测量,而不是用常规临床测量方法进行代替。然而,即使将SPRINT研究的结果用于大型人群中,SPRINT的BP测量方法仍是较少被使用。

原始出处:

Rajiv Agarwal,et al. Implications of Blood Pressure Measurement Technique for Implementation of Systolic Blood Pressure Intervention Trial (SPRINT). JAHA.2017.  https://doi.org/10.1161/JAHA.116.004536

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1843103, encodeId=9dcb18431035c, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Jul 19 14:58:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176410, encodeId=cd331e6410bd, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Feb 16 09:33:05 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267387, encodeId=675a126e38736, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Feb 16 07:58:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1843103, encodeId=9dcb18431035c, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Jul 19 14:58:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176410, encodeId=cd331e6410bd, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Feb 16 09:33:05 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267387, encodeId=675a126e38736, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Feb 16 07:58:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
    2017-02-16 天涯183

    非常好的文章

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1843103, encodeId=9dcb18431035c, content=<a href='/topic/show?id=3d052296e4e' target=_blank style='color:#2F92EE;'>#临床结局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22967, encryptionId=3d052296e4e, topicName=临床结局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7fbd46, createdName=mei531, createdTime=Wed Jul 19 14:58:00 CST 2017, time=2017-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=176410, encodeId=cd331e6410bd, content=非常好的文章, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7LIiaRZTzJ3SEfiauCzTMPW7YvPPYLNJBXG9oh6Al1icq2VQQkIHWxqXehcicTS62YKJVBhxeth3wggw/0, createdBy=7ce01621306, createdName=天涯183, createdTime=Thu Feb 16 09:33:05 CST 2017, time=2017-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1267387, encodeId=675a126e38736, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Feb 16 07:58:00 CST 2017, time=2017-02-16, status=1, ipAttribution=)]
    2017-02-16 zhaohui6731